E. Woo

发表

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Nature Communications.

Utility of the Functional Activities Questionnaire for Distinguishing Mild Cognitive Impairment From Very Mild Alzheimer Disease

David S Knopman, Po H Lu, Ellen Woo, 2010, Alzheimer disease and associated disorders.

Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults

Ellen Woo, C. Hinkin, A. Thames, 2011, AIDS and Behavior.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment

D. G. Clark, L. Apostolova, K. Hwang, 2016, Alzheimer's & dementia.

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Keith A. Johnson, Scott Ayton, Joanne L. Lord, 2015, Nature Communications.

Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment.

M. Schmitter-Edgecombe, Ellen Woo, D. Greeley, 2009, Neuropsychology.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: Rationale, psychometrics, and application

M. Schmitter-Edgecombe, E. Miller, C. Hinkin, 2009, Journal of clinical and experimental neuropsychology.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Keith A. Johnson, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keith A. Johnson, Joanne L. Lord, Colleen S. Albers, 2016, Molecular Neurobiology.

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

Sterling C. Johnson, Nick C Fox, John X. Morris, 2020, Brain communications.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2016, Scientific Reports.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Norbert Schuff, Robert C. Green, Andrew J. Saykin, 2017 .

Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment

Shantanu H. Joshi, L. Apostolova, K. Hwang, 2019, Dementia and Geriatric Cognitive Disorders Extra.

A comparison of theoretical and statistically derived indices for predicting cognitive decline

Liana G. Apostolova, Ellen Woo, John M. Ringman, 2016, Alzheimer's & dementia.

Age Effects on Cortical Thickness in Cognitively Normal Elderly Individuals

Amity E. Green, P. Thompson, L. Apostolova, 2014, Dementia and Geriatric Cognitive Disorders Extra.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Nick C Fox, 2016, Scientific Reports.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

Associations between Cortical Thickness and Metamemory in Alzheimer’s Disease

J. West, S. Risacher, L. Apostolova, 2018, Brain Imaging and Behavior.

COGNITIVE AGING AND PHYSICAL EXERCISE

Ellen Woo, M. J. Sharps, Ellen Woo, 2003 .

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

An index predictive of cognitive outcome in retired professional American Football players with a history of sports concussion

K. Guskiewicz, Ellen Woo, R. Cantu, 2016, Journal of clinical and experimental neuropsychology.

Subtle Deficits in Instrumental Activities of Daily Living in Subtypes of Mild Cognitive Impairment

Jeffrey L. Cummings, Ellen Woo, Po H. Lu, 2010, Dementia and Geriatric Cognitive Disorders.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Reaction time and response inhibition in autosomal dominant Alzheimer’s disease

J. Ringman, H. Chui, H. Maldonado, 2020, Brain and Cognition.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2018, Molecular Neurobiology.

Dance Experience and Associations with Cortical Gray Matter Thickness in the Aging Population

Shantanu H. Joshi, Theodore P. Zanto, T. Zanto, 2016, Dementia and Geriatric Cognitive Disorders Extra.

Automated 3d Mapping of Baseline and 12-month Associations between Three Verbal Memory Measures and Hippocampal Atrophy in 490 Adni Subjects and the Alzheimer's Disease Neuroimaging Initiative

Michael Weiner, Liana G. Apostolova, Paul M. Thompson, 2022 .

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Use of the MoCA in Detecting Early Alzheimer's Disease in a Spanish-Speaking Population with Varied Levels of Education

L. Apostolova, J. Ringman, D. Elashoff, 2015, Dementia and Geriatric Cognitive Disorders Extra.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

David T. Jones, Keith A. Johnson, Jeffrey N. Browndyke, 2018, Anesthesiology.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2019, Nature Communications.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Aging and Semantic Cueing during Learning and Retention of Verbal Episodic Information

M. Schmitter-Edgecombe, E. Woo, 2008, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

The Functional Impact of HIV-Associated Neuropsychological Decline

C. Hinkin, M. Wright, T. Barclay, 2009 .

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

Cortical thickness and semantic fluency in Alzheimer's disease and mild cognitive impairment.

Paul M Thompson, Ellen Woo, Andreas Lazaris, 2013, American journal of Alzheimer's disease.

Relational and imageric recall in young and older adults under conditions of high task demand

M. J. Sharps, M. A. Nunes, S. Day, 2004 .

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Keith A. Johnson, Michael W. Paul Ronald Clifford R. Andrew J. William John Weiner Aisen Petersen Jack Saykin Jagust , Sherye A. Sirrel, 2019, Scientific Reports.

Daily Activity Abilities in MCI, Alzheimer's Disease, and Healthy Controls.

Jill L. Quilici, L. Apostolova, J. Ringman, 2015, GeroPsych.

Effects of Age and Divided Attention on Memory Components Derived for the Category Exemplar Generation Task

M. Schmitter-Edgecombe, E. Woo, 2007, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Recent cocaine use and memory impairment in HIV

C. Hinkin, J. Foley, M. Wright, 2019, Applied neuropsychology. Adult.

The Functional Ability of MCI and Alzheimer’s Patients Predicts Caregiver Burden

L. Apostolova, J. Razani, M. Nakhla, 2019, GeroPsych.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Verbal memory impairment in severe closed head injury: The role of encoding and consolidation

M. Schmitter-Edgecombe, Ellen Woo, M. Wright, 2010, Journal of clinical and experimental neuropsychology.

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Sherye A. Sirrel, 2020, Scientific Reports.

Antiretroviral adherence and the nature of HIV-associated verbal memory impairment.

Ellen Woo, E. Miller, C. Hinkin, 2011, The Journal of neuropsychiatry and clinical neurosciences.

Computerized Neuropsychological Assessments

Ellen Woo, Ellen Woo, E. Woo, 2008, CNS Spectrums.

Memory Prediction Accuracy in Younger and Older Adults: A Cross-Sectional and Longitudinal Analysis

M. Schmitter-Edgecombe, Jill B Fancher, E. Woo, 2007, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Memory self-awareness and memory self-monitoring following severe closed-head injury

M. Schmitter-Edgecombe, E. Woo, 2004, Brain injury.

The “Alzheimer's Type” Profile of Semantic Clustering in Amnestic Mild Cognitive Impairment

E. Teng, J. Cummings, L. Apostolova, 2014, Journal of the International Neuropsychological Society.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Non-coding variability at the APOE locus contributes to the Alzheimerâ€TMs risk

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019 .

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

THE ROLE OF ACCELEROMETER AND GYROSCOPE SENSORS IN IDENTIFICATION OF MILD COGNITIVE IMPAIRMENT

Majid Sarrafzadeh, Migyeong Gwak, Ellen Woo, 2018, 2018 IEEE Global Conference on Signal and Information Processing (GlobalSIP).

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

Memory for performed and observed activities following traumatic brain injury

J. Fuster, M. Schmitter-Edgecombe, M. Wright, 2014, Journal of clinical and experimental neuropsychology.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects

C. Jack, M. Weiner, A. Toga, 2010, NeuroImage.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Sterling C. Johnson, Sherye A. Sirrel, Alice D. Brown, 2015, Nature Communications.

Aging and Semantic Cueing during Learning and Retention of Verbal Episodic Information

M. Schmitter-Edgecombe, E. Woo, 2008, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Sterling C. Johnson, David T. Jones, Nick C Fox, 2017, Scientific Reports.